Aptamer-Hytac Chimeras for Targeted Degradation of SARS-CoV-2 Spike-1
The development of novel tools to tackle viral processes has become a central focus in global health, during the COVID-19 pandemic. The spike protein is currently one of the main SARS-CoV-2 targets, owing to its key roles in infectivity and virion formation. In this context, exploring innovative str...
Saved in:
| Main Authors: | Carme Fàbrega, Núria Gallisà-Suñé, Alice Zuin, Juan Sebastián Ruíz, Bernat Coll-Martínez, Gemma Fabriàs, Ramon Eritja, Bernat Crosas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/13/21/1767 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aptamer–ODN Chimeras: Enabling Cell-Specific ODN Targeting Therapy
by: Bei Xia, et al.
Published: (2025-05-01) -
Advantages, applications, and future directions of in vivo aptamer SELEX: A review
by: Minchuan Lyu, et al.
Published: (2025-09-01) -
Antibody and aptamer-based therapies for osteoarthritis: Application of antibodies and promise of aptamers
by: Huaizhi Chen, et al.
Published: (2025-06-01) -
Aptamer Paper-Based Fluorescent Sensor for Determination of SARS-CoV-2 Spike Protein
by: Jincai Yang, et al.
Published: (2025-03-01) -
Targeting olfactory receptor OR2AT4: An innovative aptamer-based treatment for hair growth promotion
by: Manuel Mataix, et al.
Published: (2025-09-01)